Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities

Arch Toxicol. 2023 Jun;97(6):1825-1827. doi: 10.1007/s00204-023-03498-0. Epub 2023 May 6.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Non-alcoholic Fatty Liver Disease* / genetics
  • Pharmacogenetics*